NIFTY23,4060.33%
SENSEX74,3460.41%
BANKNIFTY54,1860.88%
NIFTY IT29,3845.57%
PHARMA24,0870.33%
AUTO26,0930.05%
FMCG48,1241.01%
METAL13,5350.17%
REALTY762.601.39%
ENERGY40,1970.02%
NIFTY23,4060.33%
SENSEX74,3460.41%
BANKNIFTY54,1860.88%
NIFTY IT29,3845.57%
PHARMA24,0870.33%
AUTO26,0930.05%
FMCG48,1241.01%
METAL13,5350.17%
REALTY762.601.39%
ENERGY40,1970.02%

ABB India Announces Significant Capital Expenditure Plan

ABB India, a leading provider of electrification and automation solutions, has unveiled a substantial capital expenditure (capex) plan for CY26, amounting to approximately USD75mn. This investment is intended to enhance the company's manufacturing capacity and research and development (R&D) capabilities, complementing the USD35mn spent in CY25.

The capex plan is expected to be allocated towards expanding manufacturing capacity, modernizing existing facilities, and developing advanced manufacturing technologies. These initiatives will enable ABB India to cater to the increasing demand from various sectors, including energy transition, data centers, transportation, and industrial automation. The company's management attributes the strong demand to the country's energy transition, grid modernization, data-center development, and rapid expansion of the metro and high-speed rail segments.

Key Highlights

Read also: Treasury Yields Experience Largest Increase in Two Weeks Following Release of Labor Market Data

  • USD75mn capex plan for CY26
  • USD35mn spent in CY25
  • Expansion of manufacturing capacity and R&D capabilities
  • Allocation towards modernization of existing facilities and development of advanced manufacturing technologies

Recommendation

We have introduced estimates for CY28 and revised our target price to Mar-28E. Our recommendation remains REDUCE on the stock, with a revised target price of Rs5,875 (55x Mar-28E EPS), reflecting premium valuations.

Investor Takeaway

Investors should consider reducing their exposure to ABB India due to the downgrade by Emkay Global.

IPOScanner Logo

IPOScanner helps investors track upcoming, live and past IPOs in one place with GMP, subscription, allotment status and listing performance insights.

About IPO Scanner

IPOScanner is built for investors who want a clear view of every IPO opportunity in one place. From upcoming issues to live subscription data, allotment updates and listing performance, we bring together the key details you need to track the primary market.

Our tools are designed to be simple, fast and investor-friendly so you can focus on evaluating businesses instead of opening multiple tabs and websites for basic information.

Details of client bank account
For any query / feedback / clarifications, email at
[email protected].

Please read all offer documents and risk disclosures carefully before investing. IPOScanner does not provide investment advice and information on this site should not be treated as a recommendation to apply for any IPO.

© 2026 IPO Scanner. All rights reserved.